These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15189947)

  • 1. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis.
    De Freitas I; Fernández-Somoza M; Essenfeld-Sekler E; Cardier JE
    Chest; 2004 Jun; 125(6):2238-46. PubMed ID: 15189947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.
    Papathanassoglou ED; Moynihan JA; Vermillion DL; McDermott MP; Ackerman MH
    Shock; 2000 Aug; 14(2):107-12. PubMed ID: 10947151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha and tumor necrosis factor receptor I, II levels in patients with severe burns.
    Yamada Y; Endo S; Inada K; Nakae H; Nasu W; Taniguchi S; Ishikura H; Tanaka T; Wakabayashi G; Taki K; Sato S
    Burns; 2000 May; 26(3):239-44. PubMed ID: 10741589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients.
    Papathanassoglou ED; Movnihan JA; Dafni O; Mantzoros CS; Ackerman MH
    Biol Res Nurs; 2003 Oct; 5(2):129-41. PubMed ID: 14531217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns.
    Yamada Y; Endo S; Nakae H; Makabe H; Sato N; Wakabayashi G; Kitamura M; Inada K; Sato S
    Burns; 2003 Dec; 29(8):799-802. PubMed ID: 14636754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of apoptosis biomarkers in severe sepsis-A pilot study.
    Chu CM; Kao KC; Huang SH; Chuang DY; Wu HP
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):32-37. PubMed ID: 27755949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
    Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival.
    Papathanassoglou ED; Moynihan JA; McDermott MP; Ackerman MH
    Crit Care Med; 2001 Apr; 29(4):709-18. PubMed ID: 11373453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome.
    Torre D; Tambini R; Manfredi M; Mangani V; Livi P; Maldifassi V; Campi P; Speranza F
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):233-6. PubMed ID: 12729991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.
    Setsuta K; Seino Y; Ogawa T; Ohtsuka T; Seimiya K; Takano T
    Circ J; 2004 Aug; 68(8):747-50. PubMed ID: 15277733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.
    Froon AH; Bemelmans MH; Greve JW; van der Linden CJ; Buurman WA
    Crit Care Med; 1994 May; 22(5):803-9. PubMed ID: 8181289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
    Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.
    Wang M; Su P
    Syst Biol Reprod Med; 2018 Apr; 64(2):93-102. PubMed ID: 29299971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.
    Kitamura M; Endo S; Sato N; Yaegashi Y; Suxzuki Y; Kojika N; Wakabayashi G
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():235-42. PubMed ID: 17564320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
    Reyna-Figueroa J; Lagunas-Martínez A; Galindo-Delgado P; Fernández-Bautista MF; Castro-Oteo PG; Martínez-Matsumoto P; Perez EM; Rosenstein Y; Limón-Rojas AE; Ortiz-Ibarra FJ; Madrid-Marina V
    Int J Hematol; 2017 May; 105(5):668-675. PubMed ID: 28144786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of death receptor pathways in oncology.
    de Vries EG; Timmer T; Mulder NH; van Geelen CM; van der Graaf WT; Spierings DC; de Hooge MN; Gietema JA; de Jong S
    Drugs Today (Barc); 2003; 39 Suppl C():95-109. PubMed ID: 14988748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
    Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
    Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.